JORDAN HEAD: Open Payments
NPI 1518610831 · SNOW HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 55 payments from 17 companies in 2025. Trend: 2023 $911 · 2024 $713 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $251 |
| Novo Nordisk Inc | 6 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 5 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, XIFAXAN, TRELEGY ELLIPTA, REXULTI, UBRELVY, LEQVIO, Wegovy.
Industry payments across NC — which companies pay providers there.
